Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 340 clinical trials
Janssen Ad26.CoV2.S Vaccine Booster in Kidney Transplant Recipients

The purpose of this research is to see if a dose of the Janssen Ad26.CoV2.S vaccine effects the immune protection in individuals who have had a kidney transplant and two or three doses of mRNA

  • 0 views
  • 26 Jul, 2022
  • 3 locations
Clazakizumab for the Treatment of Chronic Active Antibody Mediated Rejection in Kidney Transplant Recipients (IMAGINE)

This trial investigates the efficacy and safety of clazakizumab [an anti-interleukin (IL)-6 monoclonal antibody (mAb)] for the treatment of CABMR in recipients of a kidney transplant.

  • 142 views
  • 11 Mar, 2022
  • 51 locations
A Study to Evaluate Safety Tolerability Pharmacokinetics and Pharmacodynamics of Zampilimab in Adult Kidney Transplant Recipients With Chronic Allograft Injury

The main purpose of the study is to investigate the safety and tolerability of repeat dosing with zampilimab in kidney transplant recipients with deteriorating kidney function associated with

  • 46 views
  • 21 Oct, 2021
  • 8 locations
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)

transplant participants To characterize the pharmacokinetic (PK) profile of BIVV020 in kidney transplant participants To evaluate the immunogenicity of BIVV020

kidney transplant
ivig
corticosteroids
tacrolimus
  • 0 views
  • 25 Jul, 2022
  • 14 locations
BIVV020 in Prevention and Treatment of Antibody-mediated Rejection (AMR)

transplant participants To characterize the pharmacokinetic (PK) profile of BIVV020 in kidney transplant participants To evaluate the immunogenicity of BIVV020

kidney transplant
corticosteroids
tacrolimus
ivig
  • 16 views
  • 05 Aug, 2022
  • 12 locations
Establishment of a Personalized Pharmaceutical Plan in Renal or Hepatic Transplant Patients (GREPH)

The main objective of the study is to evaluate the impact of the Personalized Pharmaceutical Plan on the therapeutic adherence to immunosuppressive treatments one year after liver or kidney

  • 0 views
  • 10 Mar, 2022
  • 4 locations
Clinical Trial To Evaluate Safety And Efficacy Of US-APR2020 In Subjects With Chronic Kidney Disease Stage IV (CKD)

The aim of this Phase 2 study is to evaluate the safety and efficacy of the live biotherapeutic product, US-APR2020, in the management of patients with CKD Stage IV.

  • 0 views
  • 15 Jun, 2022
Curcumin in Kidney Transplant Recipients

The primary goal of this study is to investigate if curcumin is beneficial for kidney transplant recipients, a population with extensive baseline vascular dysfunction and cognitive impairment

  • 7 views
  • 13 Mar, 2022
  • 1 location
Abatacept Conversion in Kidney Transplantation

This is a single center, randomized, controlled phase 2b, conversion trial. This protocol has been developed to answer the question: Can patients be safely converted from monthly belatacept IV infusions to abatacept subcutaneous injections without a decrease in kidney function.The primary objective will be the difference in estimated GFR (eGFR) …

  • 0 views
  • 05 Oct, 2021
CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

This is a Phase II/III, Single-center, Prospective, Open-label, Single Arm Study of 30 Simultaneous Kidney Pancreas recipients who received a transplant at least 3 months, but no more than 5 years prior, with a history of tremors following transplantation.

  • 1 views
  • 21 Apr, 2022
  • 1 location